ACSL3 and neoplasm: We found that Acsl3 deletion reduced the percentage of Ki67+ cells in both tumor cells (Ki67+/cytokeratin+) and tumor stromal fibroblasts (Ki67+/αSMA+) (Fig. 2, G and H).